Cilostazol 100 mg Tablet Formulations Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 36
- Registration Number
- NCT00838630
- Locations
- 🇺🇸
Gateway Medical Research Inc., Saint Charles, Missouri, United States
Lamotrigine 25 mg Chewable Tablets, Non-Fasting
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00838136
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 60
- Registration Number
- NCT00836472
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00836706
- Locations
- 🇺🇸
PRACS Institute, Ltd., East Grand Forks, Minnesota, United States
Sertraline Hydrochloride 100 mg Tablets, Fasting
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00836849
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 60
- Registration Number
- NCT00835991
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Benazepril HCl 40 mg Tablets, Fasting
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00836576
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 52
- Registration Number
- NCT00835705
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Finasteride 5 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00835666
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
Sertraline Hydrochloride 100 mg Tablets, Fed
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 18
- Registration Number
- NCT00836667
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
© Copyright 2024. All Rights Reserved by MedPath